Medium Spiny Neurons (MSNs)

📖 Wiki Page

cell1550 wordssynced 2026-04-02

Medium Spiny Neurons (MSNs)

...

Medium Spiny Neurons (MSNs)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Medium Spiny Neurons (MSNs)</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:1001474](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001474)</td>
</tr>
<tr>
<td class="label">Source</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">Cerebral cortex (all layers)</td>
<td>Glutamate</td>
</tr>
<tr>
<td class="label">Thalamus (intralaminar nuclei)</td>
<td>Glutamate</td>
</tr>
<tr>
<td class="label">Substantia nigra pars compacta</td>
<td>Dopamine</td>
</tr>
<tr>
<td class="label">Raphe nuclei</td>
<td>Serotonin</td>
</tr>
<tr>
<td class="label">Basal forebrain</td>
<td>Acetylcholine</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Normal Function</td>
</tr>
<tr>
<td class="label">Dopamine</td>
<td>Motor control</td>
</tr>
<tr>
<td class="label">BDNF</td>
<td>MSN survival</td>
</tr>
<tr>
<td class="label">mTOR</td>
<td>Protein synthesis</td>
</tr>
<tr>
<td class="label">Autophagy</td>
<td>Protein clearance</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Gene silencing</td>
<td>HTT mRNA</td>
</tr>
<tr>
<td class="label">BDNF enhancement</td>
<td>TrkB agonists</td>
</tr>
<tr>
<td class="label">Autophagy enhancement</td>
<td>mTOR inhibition</td>
</tr>
<tr>
<td class="label">CRISPR editing</td>
<td>CAG repeat</td>
</tr>
<tr>
<td class="label">Model</td>
<td>Features</td>
</tr>
<tr>
<td class="label">R6/2 transgenic</td>
<td>Aggressive HD phenotype</td>
</tr>
<tr>
<td class="label">YAC128</td>
<td>Slower progression</td>
</tr>
<tr>
<td class="label">Q175 knock-in</td>
<td>More physiological</td>
</tr>
<tr>
<td class="label">QA lesion</td>
<td>Excitotoxic MSN loss</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Conservation Level</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>High</td>
</tr>
<tr>
<td class="label">Human</td>
<td>Reference</td>
</tr>
<tr>
<td class="label">Macaque</td>
<td>High</td>
</tr>
<tr>
<td class="label">Zebra finch</td>
<td>Moderate</td>
</tr>
</table>

Overview

Medium spiny neurons (MSNs) are the principal neurons of the striatum (caudate nucleus and putamen), comprising approximately 95% of striatal neurons. Named for their medium-sized cell bodies (~12-20 μm) and spiny dendrites, they are GABAergic projection neurons that form the primary output pathway of the basal ganglia. Degeneration of MSNs is the hallmark of Huntington's disease, making them critical to understanding movement disorders and basal ganglia circuit dysfunction.

Mermaid diagram (expand to render)

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

Morphology: medium spiny neuron (source: Cell Ontology)
Morphology can be inferred from Cell Ontology classification

Classification & Lineage

Parent Classification: GABAergic
Full Lineage: Neuron > GABAergic > Striatal
Brain Regions: Caudate nucleus, Putamen, Nucleus accumbens

External Database Links

[Cell Ontology (CL:1001474)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001474)
[OBO Foundry (CL:1001474)](http://purl.obolibrary.org/obo/CL_1001474)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)

Neuroanatomy

Striatal Organization

The striatum is the largest component of the basal ganglia:

Dorsal striatum: Caudate nucleus (cognitive) and putamen (motor)
Ventral striatum: Nucleus accumbens core and shell (reward/motivation)
Striosomes (patches): ~10-15% of striatum, high μ-opioid receptor, limbic inputs
Matrix: ~85-90%, sensorimotor and associative inputs

Cellular Morphology

Soma: 12-20 μm diameter, relatively small compared to cortical pyramidal cells

Dendrites:

3-5 primary dendrites radiating from soma
Covered in dense spines (10,000-15,000 per neuron)
Spine density correlates with excitatory synaptic input
Spine head volume reflects synaptic strength

Axon:

Extensive local axon collaterals (intrastriatal)
Long projection axon to globus pallidus/substantia nigra
Initial segment at ~50-100 μm from soma

Input Projections

Molecular Biology

Dopamine Receptor Expression

The fundamental division of MSNs is based on dopamine receptor expression:

D1-Expressing MSNs (Direct Pathway)

DRD1 receptor: Gs/Golf-coupled, excitatory effect of dopamine
Express substance P, dynorphin
Project to GPi and SNr (substantia nigra pars reticulata)
Express transcription factor Isl1[@lobo2010]

D2-Expressing MSNs (Indirect Pathway)

DRD2 receptor: Gi/Go-coupled, inhibitory effect of dopamine
Express enkephalin (PENK)
Project to GPe (globus pallidus externa)
Express transcription factor Foxp1[@vernay2018]

GABA Synthesis and Release

Glutamic acid decarboxylase (GAD67/GAD1, GAD65/GAD2):

Converts glutamate to GABA
GAD67 is cytosolic, involved in metabolism
GAD65 is membrane-associated, synaptic vesicle-linked

Vesicular GABA Transporter (VGAT/SLC32A1):

Loads GABA into synaptic vesicles
Also transports glycine

Transcription Factors

Key transcription factors in MSN specification:

CTIP2 (BCL11B): MSN identity, required for striatal development[@arlotta2008]
Isl1: Direct pathway specification
Foxp1/2: Indirect pathway specification
FOXP1 mutations: Cause HD-like syndrome

DARPP-32 (PPP1R1B)

Dopamine- and cAMP-regulated phosphoprotein, 32 kDa:

Key signaling integrator in MSNs
Phosphorylation at Thr34: PKA-dependent, inhibits PP1 → enhanced signaling
Phosphorylation at Thr75: Cdk5-dependent, inhibits PKA → reduced signaling
Integrates dopamine, glutamate, serotonin signals[@svenningsson2004]

Electrophysiology

Resting Properties

Resting membrane potential: ~-80 mV
Hyperpolarized due to inward-rectifier K+ channels (Kir2)
Very negative threshold: requires strong depolarization
Input resistance: 100-300 MΩ (high)

Up and Down States

MSNs exhibit bistable membrane potential states:

Down State:

Hyperpolarized (~-80 mV)
Minimal synaptic input
No action potential firing

Up State:

Depolarized (~-50 mV)
Active cortical/thalamic input
Action potentials can be generated
Transition driven by coordinated excitatory input[@wilson2007]

Firing Patterns

Low spontaneous firing rate (<1 Hz)
During up states: 5-20 Hz
Action potentials followed by afterhyperpolarization
Paired-pulse facilitation at cortical inputs

Basal Ganglia Circuits

Direct Pathway (D1-MSNs)

Cortex → Striatum (D1-MSN) → GPi/SNr → Thalamus → Cortex
+--------------------+
DISINHIBITS

D1-MSN activation inhibits GPi/SNr
Reduced GPi/SNr inhibition of thalamus
Result: Movement facilitation

Indirect Pathway (D2-MSNs)

Cortex → Striatum (D2-MSN) → GPe → STN → GPi/SNr → Thalamus → Cortex
+---------------+------+------+----------+
NET INHIBITION

D2-MSN activation inhibits GPe
Disinhibition of STN (excitatory to GPi/SNr)
Increased GPi/SNr inhibition of thalamus
Result: Movement suppression

Balanced Output

Normal motor control requires balanced direct/indirect pathway activity:

Dopamine facilitates direct pathway (D1 excitation)
Dopamine inhibits indirect pathway (D2 inhibition)
Net effect: Promotes desired movements, suppresses unwanted movements

Huntington's Disease Pathophysiology

MSN Vulnerability Pattern

Huntington's disease (HD) shows characteristic selective vulnerability:

Early stages:

Preferential D2-MSN (indirect pathway) loss
Enkephalin-expressing neurons degenerate first
Results in chorea via reduced indirect pathway suppression

Later stages:

D1-MSN (direct pathway) loss
Progressive bradykinesia develops
Both pathways eventually affected

Explanation: D2-MSNs may have lower neuroprotective BDNF signaling or higher metabolic stress[@reiner2005]

Mutant Huntingtin Mechanisms

Huntingtin protein (HTT):

Normal: 10-35 CAG repeats (polyglutamine tract)
HD: >36 CAG repeats → expanded polyQ
Mutant HTT forms aggregates (inclusion bodies)

Cellular effects:

Transcriptional dysregulation (SP1, CREB dysfunction)
Impaired BDNF trafficking from cortex
Mitochondrial dysfunction
Synaptic dysfunction (excitotoxicity)
Proteasome impairment

Excitotoxicity Hypothesis

Excessive glutamate from cortical inputs
NMDA receptor overactivation
Calcium overload
MSNs have high NMDA receptor expression
QUIN model replicates MSN loss in animals

Altered Signaling

Other Neurodegenerative Diseases

Parkinson's Disease

MSNs receive dopaminergic input from SNpc
Dopamine loss leads to:
D2-MSN disinhibition (indirect pathway overactive)
D1-MSN reduced excitation (direct pathway underactive)
Net effect: Excessive movement suppression (bradykinesia)

Multiple System Atrophy (MSA)

Striatal degeneration in MSA-P type
Combined SNpc and striatal pathology
Poor levodopa response due to postsynaptic loss

Wilson's Disease

Copper accumulation in basal ganglia
MSN degeneration
Movement disorder with psychiatric features

Therapeutic Targets

HD Symptomatic Treatment

Chorea:

Tetrabenazine (VMAT2 inhibitor): Depletes dopamine
Deutetrabenazine: Longer half-life
Antipsychotics: D2 blockade

Motor symptoms:

Physical therapy
Amantadine (may help bradykinesia)

Disease-Modifying Approaches

Experimental Approaches

Cell replacement:

Fetal striatal tissue transplants
iPSC-derived MSNs
Challenges: integration, connectivity, HD environment

Deep brain stimulation:

GPi DBS for chorea
Limited evidence for disease modification

Research Methods

Animal Models

In Vitro Models

Primary striatal cultures
iPSC-derived MSNs from HD patients
Organoid models with striatal components

Key References

Brain Atlas Resources

[Allen Cell Type Atlas - Medium Spiny Neurons](https://celltypes.brain-map.org/)
[Allen Mouse Brain Atlas - Medium Spiny Neurons](https://mouse.brain-map.org/)
[BrainSpan - Medium Spiny Neurons Developmental Transcriptome](https://brainspan.org/)
[Allen Human Brain Atlas - Medium Spiny Neurons Expression](https://human.brain-map.org/microarray)
[Neurons](/cell-types/neurons) Major brain cell type
Glia — Suppor- [Alzheimer's Disease](/diseases/alzheimers-disease)Alzhe- [Parkinson's Disease](/diseases/parkinsons-disease)d neurodegenerative disease
[Parkinson's Disease](/diseases/parkinsons-disease) Related neurodegenerative disease

External Links

[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature

Cross-species Conservation

BICAN/ABC Atlas Taxonomy

This cell type belongs to the [GABAergic](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas) class, specifically the Striatal medium spiny neuron subclass in the BICAN (Brain Initiative Cell Atlas Network) taxonomy.

The BICAN taxonomy provides a standardized classification of cell types across species, enabling cross-species comparisons of neuronal and glial cell populations.

Cell Ontology Mapping

Cell Ontology terms for this cell type:

[medium spiny neuron](https://obofoundry.org/ontology/cl/cl/1001474.html) (CL:1001474)

Cross-species Conservation Overview

This cell type shows varying degrees of conservation across model organisms:

Research Applications

Evolutionary studies: Understanding conserved mechanisms across species
Disease modeling: Cross-species validation of disease mechanisms
Drug testing: Translating findings from mouse models to human therapeutics

References

📖 View canonical wiki page →